Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus.

CONCLUSION: Rebamipide treatment for 12 weeks improved atypical GI symptoms in patients with T2DM. PMID: 27098506 [PubMed - as supplied by publisher]
Source: Diabetes and Metabolism Journal - Category: Endocrinology Tags: Diabetes Metab J Source Type: research